कवर छवि

Long survival after neoadjuvant and adjuvant camrelizumab plus chemotherapy and surgery in a patient with hepatoid adenocarcinoma of the lung: A case report

ABSTRACTHepatoid adenocarcinoma of the lung (HAL) is a rare and aggressive subtype of lung cancer. The prognosis for patients with HAL is generally poor and currently, there are only limited treatment options. Here, we present a case of a 47-year-old male diagnosed with locally advanced-stage HAL wh...

पूर्ण विवरण

में बचाया:

ग्रंथसूची विवरण
मुख्य लेखकों:	Xuhua Huang (लेखक), Linhai Zhu (लेखक), Weifeng Pan (लेखक), Jian Hu (लेखक)
स्वरूप:	पुस्तक
प्रकाशित:	Taylor & Francis Group, 2024-12-01T00:00:00Z.
विषय:	article
ऑनलाइन पहुंच:	Connect to this object online.
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन

Hepatoid adenocarcinoma of the lung
द्वारा: Livia Barreira Cavalcante, और अन्य
प्रकाशित: (2013)

Hepatoid Adenocarcinoma of the Lung
द्वारा: Catarina Lucas, और अन्य
प्रकाशित: (2018)

Hepatoid Adenocarcinoma of the Lung:
द्वारा: Yasmine Laraqui Houssein, और अन्य
प्रकाशित: (2022)

Hepatoid adenocarcinoma of the lung mimicking metastatic hepatocellular carcinoma
द्वारा: Yu Miyama, और अन्य
प्रकाशित: (2021)

Hepatoid Adenocarcinoma of the Urachus
द्वारा: Daniel Fernando Gallego, और अन्य
प्रकाशित: (2016)

Clinicopathological Characteristics of Gastric Hepatoid Adenocarcinoma
द्वारा: Jung Bin Yoon, और अन्य
प्रकाशित: (2017)

SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma
द्वारा: Naomi Fei, और अन्य
प्रकाशित: (2021)

Cost-effectiveness analysis of camrelizumab plus chemotherapy as first-line treatment for advanced squamous NSCLC in China
द्वारा: Taihang Shao, और अन्य
प्रकाशित: (2022)

Therapeutic Approaches to Gastric Hepatoid Adenocarcinoma: Current Perspectives
द्वारा: Søreide JA
प्रकाशित: (2019)

Whole-exome sequencing and bioinformatics analysis of a case of non-alpha-fetoprotein-elevated lung hepatoid adenocarcinoma
द्वारा: Yao Yao, और अन्य
प्रकाशित: (2022)

Hepatoid adenocarcinoma of stomach: Case report of a rare histological variant
द्वारा: Vidisha Mahajan, और अन्य
प्रकाशित: (2014)

Neoadjuvant or adjuvant chemotherapy: what is the best treatment of muscle invasive bladder cancer?
द्वारा: Nabil Ismaili, और अन्य
प्रकाशित: (2011)

Peritoneal hepatoid carcinoma with chemotherapy response and possible stem cell involvement
द्वारा: Christine K.C. Loo, और अन्य
प्रकाशित: (2018)

Hepatoid adenocarcinoma of lung: A diagnostic challenge - Series of six cases with histopathological, predictive molecular and PD.L1 assessment
द्वारा: Sunil Pasricha, और अन्य
प्रकाशित: (2021)

A Stage 4 Hepatoid Adenocarcinoma of the Endometrium: a Case Report and Review of Literature
द्वारा: Duygu Altin, और अन्य
प्रकाशित: (2018)

Hepatoid adenocarcinoma in ureter with next-generation sequencing: A case report and literature review
द्वारा: Mengxin Lu, और अन्य
प्रकाशित: (2024)

Hepatoid adenocarcinoma of distal ileum without inflammatory bowel disease; A rare case
द्वारा: Daisuke Kiyozawa, और अन्य
प्रकाशित: (2019)

Case Report: Chemotherapy-free treatment with camrelizumab and anlotinib for elderly patients with KRAS and TP53 mutated advanced lung cancer
द्वारा: Wenbo Qi, और अन्य
प्रकाशित: (2023)

Immunohistochemical characteristics and potential therapeutic regimens of hepatoid adenocarcinoma of the stomach: a study of 139 cases
द्वारा: Xuesong Yang, और अन्य
प्रकाशित: (2024)

Comparison of Neoadjuvant Immunotherapy Plus Chemotherapy versus Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study
द्वारा: Zhao J, और अन्य
प्रकाशित: (2023)

Comprehensive Treatment of Trans-Arterial Chemoembolization Plus Lenvatinib Followed by Camrelizumab for Advanced Hepatocellular Carcinoma Patients
द्वारा: Juanfang Liu, और अन्य
प्रकाशित: (2021)

Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer
द्वारा: Maria Fernanda Imperio Pereira, और अन्य
प्रकाशित: (2024)

Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung cancer
द्वारा: Van Laar Ryan K
प्रकाशित: (2012)

Neoadjuvant Chemotherapy Current Applications in Clinical Practice
प्रकाशित: (2012)

Neoadjuvant Chemotherapy Increasing Relevance in Cancer Management
प्रकाशित: (2013)

The Outcomes of Primary Debulking Surgery and Neoadjuvant Chemotherapy in Advanced Ovarian Cancer
द्वारा: Dino Rinaldy, और अन्य
प्रकाशित: (2016)

Successful neoadjuvant chemotherapy plus sintilimab for locally advanced cervical cancer: case series and review of the literature
द्वारा: Linlin Liu, और अन्य
प्रकाशित: (2023)

Comparison of the efficacy and survival analysis of neoadjuvant chemotherapy for Her-2-positive breast cancer
द्वारा: Li S, और अन्य
प्रकाशित: (2018)

Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
द्वारा: Soo Young Jeong, और अन्य
प्रकाशित: (2019)

Prognostic nutritional index before adjuvant chemotherapy predicts chemotherapy compliance and survival among patients with non-small-cell lung cancer
द्वारा: Shimizu K, और अन्य
प्रकाशित: (2015)

A case of successful maintained pregnancy after neoadjuvant chemotherapy plus radical surgery for stage IB3 cervical cancer diagnosed at 13 weeks
द्वारा: Ying Guo, और अन्य
प्रकाशित: (2020)

EGFR Inhibitors for Neoadjuvant and Adjuvant Therapy of NSCLC
द्वारा: Fabio Villa
प्रकाशित: (2015)

Taxanes in adjuvant and neoadjuvant therapy for breast cancer
द्वारा: S. V. Limareva
प्रकाशित: (2014)

Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review
द्वारा: Hao Tian, और अन्य
प्रकाशित: (2021)

Triple composite tumor of stomach: A rare combination of alpha fetoprotein positive hepatoid adenocarcinoma, tubular adenocarcinoma and large cell neuroendocrine carcinoma
द्वारा: Lipika Lipi, और अन्य
प्रकाशित: (2014)

Cost-Effectiveness Analysis of Camrelizumab Plus Chemotherapy vs. Chemotherapy Alone as the First-Line Treatment in Patients With IIIB-IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Without EGFR and ALK Alteration from a Perspective of Health - Care System in China
द्वारा: Chen Zhu, और अन्य
प्रकाशित: (2021)

Functional heterogeneity of cancer-associated fibroblasts with distinct neoadjuvant immunotherapy plus chemotherapy response in esophageal squamous cell carcinoma
द्वारा: Jun Jiang, और अन्य
प्रकाशित: (2024)

Cost-Effectiveness of Domestic PD-1 Inhibitor Camrelizumab Combined With Chemotherapy in the First-Line Treatment of Advanced Nonsquamous Non-Small-Cell Lung Cancer in China
द्वारा: Liu Qiao, और अन्य
प्रकाशित: (2021)

Economic Evaluation of First-Line Camrelizumab for Advanced Non-small-cell Lung Cancer in China
द्वारा: Guiyuan Xiang, और अन्य
प्रकाशित: (2021)

The Outcome of Induction Chemotherapy, Followed by Neoadjuvant Chemoradiotherapy and Surgery, in Locally Advanced Rectal Cancer
द्वारा: Ali Yaghobi Joybari, और अन्य
प्रकाशित: (2021)